Inari Medical, Inc. (NASDAQ:NARI) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Caroline Corner - Westwicke, IR Bill Hoffman - President and CEO Mitch Hill - Chief Financial Officer Drew Hykes - Chief Operating Officer Dr. Tom Tu - Chief Medical Officer Conference Call Participants Cecilia Furlong - Morgan Stanley Larry Biegelsen - Wells Fargo Marie Thibault - BTIG Priya Sachdeva - SVB Leerink Operator Good day, ladies and gentlemen. And welcome to Inari Medical, Inc. Thi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-39293 Inari Medical, Inc. (Exact Name of Registrant as Specified in its Charter) | | Trading | | | --- ...

Inari Medical, Inc. (NASDAQ:NARI) Q2 2021 Earnings Conference Call August 10, 2021 4:30 PM ET Company Participants Caroline Corner - Investor Relations Bill Hoffman - President & Chief Executive Officer Mitch Hill - Chief Financial Officer Drew Hykes - Chief Operating Officer Tom Tu - Chief Medical Officer Conference Call Participants Bob Hopkins - Bank of America Cecilia Furlong - Morgan Stanley Larry Biegelsen - Wells Fargo Bill Plovanic - Canaccord Danielle Antalffy - SVB Leerink Marie Thibault - BTIG Op ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-39293 Inari Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 45-2902923 ( Stat ...

Inari Medical, Inc. (NASDAQ:NARI) Q1 2021 Earnings Conference Call May 11, 2021 4:30 PM ET Company Participants Caroline Corner - Westwicke Partners, LLC William Hoffman - President & Chief Executive Officer Mitchell Hill - Chief Financial Officer Andrew Hykes - Chief Operating Officer Thomas Tu - Chief Medical Officer Conference Call Participants Cecilia Furlong - Morgan Stanley Larry Biegelsen - Wells Fargo Securities, LLC Danielle Lastly - SVB Leerink Bill Plovanic - Canaccord Marie Thibault - BTIG Oper ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________to ___________ Commission File Number: 001-39293 Inari Medical, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 45-2902923 ( Sta ...

Inari Medical, Inc. (NASDAQ:NARI) Q4 2020 Earnings Conference Call March 9, 2021 4:30 PM ET Company Participants Caroline Corner - Westwicke Partners, LLC William Hoffman - President and Chief Executive Officer Mitchell Hill - Chief Financial Officer Andrew Hykes - Chief Operating Officer Thomas Tu - Chief Medical Officer Conference Call Participants Robert Hopkins - Bank of America Merrill Lynch David Lewis - Morgan Stanley Lawrence Biegelsen - Wells Fargo Securities, LLC William Plovanic - Canaccord Genui ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39293 Inari Medical, Inc. (Exact name of Registrant as specified in its Charter) Delaware 45-2902923 (State or other jurisdiction of ...

MEDICAL Investor Presentation NASDAQ: NARI November 2020 This presentation (together with any other statements or information that we may make in connection therewith) may contain are forward-looking statements. All statements other than statements of historical fact could be deemed forward-looking, including any estimates of our total addressable market, future results of operations, financial position, research and development costs, capital requirements and our needs for additional financing; our busines ...

Inari Medical, Inc. (NASDAQ:NARI) Q3 2020 Earnings Conference Call November 12, 2020 4:30 PM ET Company Participants Caroline Corner - Investor Relations, Westwicke Partners Bill Hoffman - Chief Executive Officer Mitch Hill - Chief Financial Officer Conference Call Participants Bob Hopkins - Bank of America Securities David Lewis - Morgan Stanley Larry Biegelsen - Wells Fargo William Plovanic - Canaccord Genuity Danielle Antalffy - SVB Leerink Operator Ladies and gentlemen, thank you for standing by. And we ...